Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390059
Status:
RECRUITING
Last Update Posted:
2024-05-03
First Post:
2024-02-29
Brief Title:
EF-39 PANOVA-4 Study of Tumor Treating Fields Concomitant With Atezolizumab Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor:
NovoCure GmbH
Organization:
NovoCure Ltd
Organization Data
Organization:
NovoCure Ltd
Class:
INDUSTRY
Study ID:
EF-39
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NovoCure GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None